← All Scienture Holdings, INC filings

Scienture Holdings, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
SCNX
Scienture Holdings, INC
Form 4: Scienture Co-CEO Hariharan Boosts Stake, Converts Preferred Shares
Scienture Holdings Co-CEO Shankar Hariharan reported significant changes in his beneficial ownership, including preferred stock conversions and restricted stock awards.
NASDAQ
SCNX
Scienture Holdings, INC
Form 4: Scienture Co-CEO Mani Reports Significant Stock Transactions
Narasimhan Mani, President & Co-CEO of Scienture Holdings, Inc., reported multiple transactions including conversion of preferred stock and awards of restricted common stock.
NASDAQ
SCNX
Scienture Holdings, INC
4/A: TRxADE HEALTH CEO Corrects Ownership Details in Amended SEC Filing
Surendra Ajjarapu, CEO of TRxADE HEALTH, files an amended SEC Form 4 to correct previously reported information regarding securities acquired, beneficial ownership, and form of ownership.
NASDAQ
SCNX
Scienture Holdings, INC
4/A: TRxADE HEALTH Executive Corrects Ownership Disclosure After Stock Grant
Prashant Patel, Interim CFO and Director of TRxADE HEALTH, files an amended Form 4 to correct details regarding a stock grant and beneficial ownership.